Biomagnetic Technologies of San Diego reported a sharp increase in sales and a lower net loss for fiscal 1997 (end-September) as the company began recognizing revenue from magnetic source imaging systems that had been delayed from shipping in 1996. BTI
Biomagnetic Technologies of San Diego reported a sharp increase in sales and a lower net loss for fiscal 1997 (end-September) as the company began recognizing revenue from magnetic source imaging systems that had been delayed from shipping in 1996. BTI also reported that a European customer is developing a new version of its Magnes technology for applications other than the brain.
For the year, BTI posted revenues of $11 million, compared with $1.4 million in fiscal 1996, while the company's net loss shrank to $3 million, compared with $14.8 million the year before. BTI's revenues for the year included sales from the company's first Magnes 1300C system, which is being developed at the European site.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.